Tonje Sofie Dalen

  • Research technologist; MSc, biomedicine
  • +47 22 78 13 53; 415 19 541

Has a shared position with 50% as Biomedical Scientist Specialist focusing on biobanking, logistics and laboratory work in clinical lung cancer studies combined with a 50% position as coordinator for the National expert group for lung cancer research in Norway. Main clinical studies: DART, COMIT-2, NIPU and Impress Norway.

Research group

 

Publications 2024

Haakensen VD, Öjlert ÅK, Thunold S, Farooqi S, Nowak AK, Chin WL, Grundberg O, Szejniuk WM, Cedres S, Sørensen JB, Dalen TS, Lund-Iversen M, Bjaanæs M, Helland Å (2024)
UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma - A phase II randomised trial
Eur J Cancer, 202, 113973
DOI 10.1016/j.ejca.2024.113973, PubMed 38447379

Scroll to top